메뉴 건너뛰기




Volumn 18, Issue 1, 2005, Pages 44-49

Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease

Author keywords

Aldosterone; angiotensin converting enzyme inhibitor; chronic renal disease; diabetic nephropathy; mineralocorticoid receptor blockade

Indexed keywords

COLLAGEN TYPE 4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; PROTEIN; SPIRONOLACTONE; TRANDOLAPRIL;

EID: 13244298395     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.06.029     Document Type: Article
Times cited : (117)

References (34)
  • 1
    • 73049130173 scopus 로고
    • Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro
    • J. Crabbe Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro J Clin Invest 40 1961 2103 2106
    • (1961) J Clin Invest , vol.40 , pp. 2103-2106
    • Crabbe, J.1
  • 2
    • 0030814350 scopus 로고    scopus 로고
    • Aldosterone, salt and cardiac fibrosis
    • J.W. Funder Aldosterone, salt and cardiac fibrosis Clin Exp Hypertens 19 1997 885 899
    • (1997) Clin Exp Hypertens , vol.19 , pp. 885-899
    • Funder, J.W.1
  • 3
    • 0030737574 scopus 로고    scopus 로고
    • Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro
    • A. Sato, J.P. Liu, J.W. Funder Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro Endocrinology 138 1997 3410 3416
    • (1997) Endocrinology , vol.138 , pp. 3410-3416
    • Sato, A.1    Liu, J.P.2    Funder, J.W.3
  • 4
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Randomized Aldactone Evaluation Study J.
    • B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes Randomized Aldactone Evaluation Study The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes8
  • 5
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators M.
    • B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, M. Gatlin Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
    • (2003) N Engl J Med , vol.348 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3    Neaton, J.4    Martinez, F.5    Roniker, B.6    Bittman, R.7    Hurley, S.8    Kleiman, J.9    Gatlin10
  • 6
    • 0141617520 scopus 로고    scopus 로고
    • Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
    • A. Sato, T. Saruta Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy Am J Hypertens 16 2003 781 788
    • (2003) Am J Hypertens , vol.16 , pp. 781-788
    • Sato, A.1    Saruta, T.2
  • 7
    • 0035022922 scopus 로고    scopus 로고
    • Aldosterone and the hypertensive kidney: Its emerging role as a mediator of progressive renal dysfunction: A paradigm shift
    • M. Epstein Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift J Hypertens 19 2001 829 842
    • (2001) J Hypertens , vol.19 , pp. 829-842
    • Epstein, M.1
  • 8
    • 0141730383 scopus 로고    scopus 로고
    • Aldosterone receptor blockade and the role of eplerenone: Evolving perspectives
    • M. Epstein Aldosterone receptor blockade and the role of eplerenone evolving perspectives Nephrol Dial Transplant 18 2003 1984 1992
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1984-1992
    • Epstein, M.1
  • 10
    • 0034119204 scopus 로고    scopus 로고
    • Local angiotensin II and transforming growth factor-beta 1 in renal fibrosis of rats
    • Y. Sun, J. Zhang, J.Q. Zhang, F.J. Ramires Local angiotensin II and transforming growth factor-beta 1 in renal fibrosis of rats Hypertension 35 2000 1078 1084
    • (2000) Hypertension , vol.35 , pp. 1078-1084
    • Sun, Y.1    Zhang, J.2    Zhang, J.Q.3    Ramires, F.J.4
  • 12
    • 0037222490 scopus 로고    scopus 로고
    • Effectiveness of aldosterone blockade in patients with diabetic nephropathy
    • A. Sato, K. Hayashi, M. Naruse, T. Saruta Effectiveness of aldosterone blockade in patients with diabetic nephropathy Hypertension 41 2003 64 68
    • (2003) Hypertension , vol.41 , pp. 64-68
    • Sato, A.1    Hayashi, K.2    Naruse, M.3    Saruta, T.4
  • 13
    • 0034745049 scopus 로고    scopus 로고
    • Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy
    • A. Sato, T. Saruta Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy J Int Med Res 29 2001 13 21
    • (2001) J Int Med Res , vol.29 , pp. 13-21
    • Sato, A.1    Saruta, T.2
  • 14
    • 0032951417 scopus 로고    scopus 로고
    • Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension
    • A. Sato, Y. Suzuki, T. Saruta Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension Hypertens Res 22 1999 17 27
    • (1999) Hypertens Res , vol.22 , pp. 17-27
    • Sato, A.1    Suzuki, Y.2    Saruta, T.3
  • 15
    • 0027517659 scopus 로고
    • The effect of angiotensin-conveting-enzyme inhibition on diabetic nephropathy
    • Collaborative Study Group R.D.
    • E.J. Lewis, L.G. Hunsicker, R.P. Bain, R.D. Rohd Collaborative Study Group The effect of angiotensin-conveting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
    • (1993) N Engl J Med , vol.329 , pp. 1456-1462
    • Lewis, E.J.1    Hunsicker, L.G.2    Bain, R.P.3    Rohd4
  • 16
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
    • Heart Outcome Prevention Evaluation (HOPE) Study Investigators
    • Heart Outcome Prevention Evaluation (HOPE) Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy Lancet 355 2000 253 259
    • (2000) Lancet , vol.355 , pp. 253-259
  • 17
    • 0030604561 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
    • The GISEN Group
    • The GISEN Group Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1863
    • (1997) Lancet , vol.349 , pp. 1857-1863
  • 18
    • 15844368318 scopus 로고    scopus 로고
    • Effect of the angiotensin-conveting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
    • The Angiotensin-Converting-Enzyme Inhibitor in Progressive Renal Insufficiency Study Group P.
    • G. Maschio, D. Alberti, G. Janin, F. Locatelli, J.F. Mann, M. Motolese, C. Ponticelli, E. Ritz, P. Zucchelli The Angiotensin-Converting-Enzyme Inhibitor in Progressive Renal Insufficiency Study Group Effect of the angiotensin-conveting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
    • (1996) N Engl J Med , vol.334 , pp. 939-945
    • Maschio, G.1    Alberti, D.2    Janin, G.3    Locatelli, F.4    Mann, J.F.5    Motolese, M.6    Ponticelli, C.7    Ritz, E.8    Zucchelli9
  • 19
    • 0035124068 scopus 로고    scopus 로고
    • Late escape from the antiproteinuric effect of ACE inhibitors in nondiabetic renal disease
    • T. Shiigai, M. Shichiri Late escape from the antiproteinuric effect of ACE inhibitors in nondiabetic renal disease Am J Kidney Dis 37 2001 477 483
    • (2001) Am J Kidney Dis , vol.37 , pp. 477-483
    • Shiigai, T.1    Shichiri, M.2
  • 20
    • 0036314951 scopus 로고    scopus 로고
    • Aldosterone breakthrough during angitensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats
    • M. Naruse, A. Tanabe, A. Sato, S. Takagi, K. Tsuchiya, T. Imaki, K. Takano Aldosterone breakthrough during angitensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats Hypertension 40 2002 28 33
    • (2002) Hypertension , vol.40 , pp. 28-33
    • Naruse, M.1    Tanabe, A.2    Sato, A.3    Takagi, S.4    Tsuchiya, K.5    Imaki, T.6    Takano, K.7
  • 21
    • 0037431774 scopus 로고    scopus 로고
    • Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomized controlled trial
    • N. Nakao, A. Yoshimura, H. Morita, M. Takada, T. Kayano, T. Ideura Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE) a randomized controlled trial Lancet 361 2003 117 124
    • (2003) Lancet , vol.361 , pp. 117-124
    • Nakao, N.1    Yoshimura, A.2    Morita, H.3    Takada, M.4    Kayano, T.5    Ideura, T.6
  • 22
    • 0029762716 scopus 로고    scopus 로고
    • High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes
    • A. Sato, J.W. Funder High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes Endocrinology 137 1996 4145 4153
    • (1996) Endocrinology , vol.137 , pp. 4145-4153
    • Sato, A.1    Funder, J.W.2
  • 24
    • 0028079451 scopus 로고
    • Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen
    • M. Wakisaka, M.J. Spiro, R.G. Spiro Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen Diabetes 43 1994 95 103
    • (1994) Diabetes , vol.43 , pp. 95-103
    • Wakisaka, M.1    Spiro, M.J.2    Spiro, R.G.3
  • 25
    • 0031921409 scopus 로고    scopus 로고
    • Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: Application in diabetic nephropathy
    • D. Ellis, K.Y. Forrest, J. Erbey, T.J. Orchard Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury application in diabetic nephropathy Clin Chem 44 1998 950 956
    • (1998) Clin Chem , vol.44 , pp. 950-956
    • Ellis, D.1    Forrest, K.Y.2    Erbey, J.3    Orchard, T.J.4
  • 26
    • 0141926500 scopus 로고    scopus 로고
    • Effects of the angiotensin II type 1 receptor antagonist candesartan compared with angiotensin-converting enzyme inhibitors on urinary excretions of albumin and type IV collagen in patients with diabetic nephropathy
    • A. Sato, M. Tabata, K. Hayashi, T. Saruta Effects of the angiotensin II type 1 receptor antagonist candesartan compared with angiotensin-converting enzyme inhibitors on urinary excretions of albumin and type IV collagen in patients with diabetic nephropathy Clin Exp Nephrol 7 2003 215 220
    • (2003) Clin Exp Nephrol , vol.7 , pp. 215-220
    • Sato, A.1    Tabata, M.2    Hayashi, K.3    Saruta, T.4
  • 27
    • 0036191924 scopus 로고    scopus 로고
    • Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels
    • R. Agarwal, S. Siva, S.R. Dunn, K. Sharma Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels Am J Kidney Dis 39 2002 486 492
    • (2002) Am J Kidney Dis , vol.39 , pp. 486-492
    • Agarwal, R.1    Siva, S.2    Dunn, S.R.3    Sharma, K.4
  • 28
    • 0028435192 scopus 로고
    • Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli
    • M. Fukui, T. Nakamura, I. Ebihara, Y. Makita, S. Osada, Y. Tomino, H. Koide Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli J Lab Clin Med 123 1994 763 768
    • (1994) J Lab Clin Med , vol.123 , pp. 763-768
    • Fukui, M.1    Nakamura, T.2    Ebihara, I.3    Makita, Y.4    Osada, S.5    Tomino, Y.6    Koide, H.7
  • 30
    • 0037116558 scopus 로고    scopus 로고
    • Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction. Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression
    • J. Bauersachs, M. Heck, D. Fraccarollo, S.K. Hildemann, G. Ertl, M. Wehling, M. Christ Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction. Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression J Am Coll Cardiol 39 2002 351 358
    • (2002) J Am Coll Cardiol , vol.39 , pp. 351-358
    • Bauersachs, J.1    Heck, M.2    Fraccarollo, D.3    Hildemann, S.K.4    Ertl, G.5    Wehling, M.6    Christ, M.7
  • 31
    • 0034651798 scopus 로고    scopus 로고
    • Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failyure
    • C.A. Farquharson, A.D. Struthers Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failyure Circulation 101 2000 594 597
    • (2000) Circulation , vol.101 , pp. 594-597
    • Farquharson, C.A.1    Struthers, A.D.2
  • 32
    • 0034619571 scopus 로고    scopus 로고
    • Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition
    • J. Bauersachs, D. Fraccarollo, G. Ertl, N. Gretz, M. Wehling, M. Christ Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition Circulation 102 2000 2325 2328
    • (2000) Circulation , vol.102 , pp. 2325-2328
    • Bauersachs, J.1    Fraccarollo, D.2    Ertl, G.3    Gretz, N.4    Wehling, M.5    Christ, M.6
  • 34
    • 0001847493 scopus 로고    scopus 로고
    • Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria
    • M. Epstein, V. Buckalew Jr, F. Martinez, J. Altamirano, B. Roniker, J. Kleiman, S. Krause Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria Am J Hypertens 15 2002 24A
    • (2002) Am J Hypertens , vol.15
    • Epstein, M.1    Buckalew Jr., V.2    Martinez, F.3    Altamirano, J.4    Roniker, B.5    Kleiman, J.6    Krause, S.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.